In this newly created role, Laura will be tasked with leading creative excellence and innovation across the practice’s global teams and client portfolio.
Tag Archive for: healthcare communications
The partnership supercharges healthcare product commercialization using Rainbird’s next-generation Decision Intelligence platform.
IPG Health Medical Communications’ industry-leading early career training program, Fuel (Future Experts and Leaders), has received an Award for delivering sustainable training to new recruits in the healthcare communications sector. The Princess Royal Training Awards recognize organizations that demonstrate exceptional commitment to learning and development.
It’s been a banner couple of years for Spectrum Science and CrowdPharm, and the time was simply right for the agencies to take the next transformative step.
The global alliance will help the agency accelerate early success into key regional markets.
In the age of artificial intelligence (AI), the boundaries of communication and information dissemination are expanding exponentially. Key opinion leader (KOL) videos are no exception. The ability to create lifelike avatars to deliver content in a way that’s nearly indistinguishable from human presence is not only here, but it’s here to stay.
Koffer has deep experience in strategic brand development to consumer audiences, including healthcare, retail and CPG. This highly valuable experience will bolster CMI Media Group’s patient/consumer offerings with a complement to their healthcare provider offerings. Her strategic vision will help the company continue to deliver on excellence in meaningful connections with key audiences for their healthcare clients.
In the latest stride of its strategic growth plan, The Bloc has announced a formal partnership with Impact Communication Partners, Inc., and its sister agency, BioMedCom Partners, Inc. Impact, an esteemed privately-owned medical communications firm based in Connecticut, boasts a legacy of over 40 years in the US medical communications market.
The former AstraZeneca and Vertex Pharmaceuticals executive bolsters the agency’s value, access, and reimbursement practice.